Guidelines/Position Statements
| 2024 | – | 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery | ||||||||||||||||||||||
| 2024 | – | SCMR Guidelines for Reporting CMR Examinations in Patients with Congenital Heart Disease | ||||||||||||||||||||||
| 2024 | – | Joint CV Society Statement on HE/DEI | ||||||||||||||||||||||
| 2024 | – | 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy | ||||||||||||||||||||||
| 2024 | – | SCMR Expert Consensus Statement for CMR of Patients with a Cardiac Implantable Electronic Device | ||||||||||||||||||||||
| 2024 | – | Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging | ||||||||||||||||||||||
| 2024 | – | Competency Based Curriculum for Cardiovascular Magnetic Resonance | ||||||||||||||||||||||
| 2023 | – | 4D Flow Cardiovascular Magnetic Resonance Consensus Statement: 2023 Update | ||||||||||||||||||||||
| 2022 | – | SCMR Consensus Statement for Acquired and Non-structural Pediatric Heart Disease | ||||||||||||||||||||||
| 2022 | – | SCMR/SNMMI/ACR/ASNC Joint Credentialing Statement for Cardiac PET/MRI | ||||||||||||||||||||||
| 2022 | – | SCMR/ | ||||||||||||||||||||||
| 2022 | – | SCMR Guidelines for Reporting CMR Examinations
| ||||||||||||||||||||||
| 2021 | – | AHA/ | ||||||||||||||||||||||
| 2021 | – | Standards for Writing SCMR Endorsed Guidelines, Expert Consensus, and Recommendations | ||||||||||||||||||||||
| 2021 | – | SCMR Position Statement – CMR in Women with Cardiovascular Disease
| ||||||||||||||||||||||
| 2021 | – | ASNC/ | ||||||||||||||||||||||
| 2021 | – | ASNC/ | ||||||||||||||||||||||
| 2020 | – | SCMR Position Paper – Clinical Indications for CMR
| ||||||||||||||||||||||
| 2020 | – | SCMR Standardized Interpretation and Post-Processing 2020 Update
| ||||||||||||||||||||||
| 2020 | – | SCMR Standardized Imaging Protocols 2020 Update
| ||||||||||||||||||||||
| 2020 | – | AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy | ||||||||||||||||||||||
| 2019 | – | SCMR Position Statement: Clinical Practice of CMR | ||||||||||||||||||||||
| 2017 | – | SCMR Consensus Statement on CMR Mapping of T1, T2, and T2* | ||||||||||||||||||||||
| 2013 | – | SCMR Protocols for Adult & Pediatric Congenital Heart Disease
| ||||||||||||||||||||||
Chinese
Spanish
Japanese
Korean
French
RomanianAppropriate Use Criteria
Other Documents
PersianPolicies
The Society for Cardiovascular Magnetic Resonance (SCMR) is the international professional society that strives to improve cardiovascular health by advancing the field of cardiovascular magnetic resonance (CMR). Read More.
The Society for Cardiovascular Magnetic Resonance (SCMR) recognizes that the shocking events in the United States and subsequent global #BlackLivesMatter protests, have a profound impact in our communities. Read More.
The Society for Cardiovascular Magnetic Resonance (SCMR) is deeply concerned about the escalating humanitarian crisis in the heart of Europe and the safety of the people of Ukraine.
The Society for Cardiovascular Magnetic Resonance (SCMR) is dedicated to ensuring the integrity of our research-related activities. Therefore, we work to responsibly identify and manage financial conflicts of interest (FCOI). Read More about our FCOI policy and the ways that we comply with the federal Public Health Service’s (PHS) requirements for institutions that seek research funding.
